Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 10,issue 1  (01-2010)

Period of time： 2010年1期

Publisher： Bentham Science Publishers

Founded in： 2001

Total resources： 51

E-ISSN： 2212-3873|10|1

ISSN： 1871-5303

Subject： R9 Pharmacy

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 10,issue 1

Menu

Imatinib Mesylate (Gleevec©): Targeted Therapy Against Cancer with Immune Properties

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 10,issue 1 , Vol. 10, Iss. 1, 2010-03 , pp. 1-7

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Cross-talk Between Exogenous Statins and Endogenous High-Density Lipoprotein in Anti-Inflammatory and Anti-Atherogenic Actions

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 10,issue 1 , Vol. 10, Iss. 1, 2010-03 , pp. 8-15

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

SIRT1, a Calorie Restriction Mimetic, in a New Therapeutic Approach for Type 2 Diabetes Mellitus and Diabetic Vascular Complications

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 10,issue 1 , Vol. 10, Iss. 1, 2010-03 , pp. 16-24

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Metabolic Syndrome Components in Murine Models

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 10,issue 1 , Vol. 10, Iss. 1, 2010-03 , pp. 25-40

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Antitumor Activities of Interleukin-27 on Melanoma

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 10,issue 1 , Vol. 10, Iss. 1, 2010-03 , pp. 41-46

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Diagnostic Usefulness of Tumor Markers in the Thyroid Cytological Samples Extracted by Fine-Needle Aspiration Biopsy

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 10,issue 1 , Vol. 10, Iss. 1, 2010-03 , pp. 47-56

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Does It Make Sense that Diabetes is Reciprocally Associated with Periodontal Disease?

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 10,issue 1 , Vol. 10, Iss. 1, 2010-01 , pp. 57-70

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

The Central Role of Macrophages in Trypanosomiasis-Associated Anemia:Rationale for Therapeutical Approaches

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 10,issue 1 , Vol. 10, Iss. 1, 2010-03 , pp. 71-82

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Erratum

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 10,issue 1 , Vol. 10, Iss. 1, 2010-03 , pp. 83-83

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Total 9 item(s)